Enterprise League logo
ACGENETIC Therapeutics Logo

ACGENETIC Therapeutics

Irvine, United States (US) · Health and Medical

We built this page from public sources. What we do with your data

Do you work at ACGENETIC Therapeutics?

Claim this profile to manage your company.

Verified by Enterprise League

Data quality

Complete · Accuracy

AcGenetic Therapeutics is a US-based biotechnology research company located in Irvine, California, dedicated to developing personalized gene-editing therapies for rare genetic diseases.Our mission centers on tackling Limb-Girdle Muscular Dystrophy Type 2B/R2 (LGMD 2B/R2), a debilitating condition affecting muscle function, driven by a deep understanding of the disease’s origins – the founder’s personal experience as a patient and his family.We leverage cutting-edge stem cell therapy and gene-editing technologies, supported by the FDA’s regulatory framework for individualized medicine, to create innovative solutions.

Overview

AcGenetic Therapeutics is a US-based biotechnology research company located in Irvine, California, dedicated to developing personalized gene-editing therapies for rare genetic diseases.

Our mission centers on tackling Limb-Girdle Muscular Dystrophy Type 2B/R2 (LGMD 2B/R2), a debilitating condition affecting muscle function, driven by a deep understanding of the disease’s origins – the founder’s personal experience as a patient and his family.

We leverage cutting-edge stem cell therapy and gene-editing technologies, supported by the FDA’s regulatory framework for individualized medicine, to create innovative solutions. Beyond LGMD 2B/R2, we are committed to expanding our research platform to address a broader spectrum of rare genetic disorders, offering hope to patients and families worldwide.
Visit Official Website

Most teams do this before shortlisting


Contact Details

sales@acgenetic.com

Irvine, United States (US)

Founded

2021

Company Type

Private Limited Company

Employees

2-10

Categories

Biopharma
Life Science
Biotechnology

Awards

• 2026 OpenSee all

Services

Default Product Image
Personalized Gene-Editing Therapies
Biotechnology

Development of individualized stem cell therapies utilizing gene-editing technologies to treat rare genetic diseases, initially focused on Limb-Girdle Muscular Dystrophy Type 2B/R2.

N/A

Companies teams usually look at after ACGENETIC Therapeutics

Comparing a few options usually leads to better decisions






  • Save companies to compare later. Useful when sharing options with your team

This is how your company profile looks to others.